Non-homogeneity in the efficiency evaluation of health systems.
Data envelopment analysis
Efficiency evaluation
Health systems
Non-homogeneity
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
10 Nov 2023
10 Nov 2023
Historique:
received:
31
05
2023
accepted:
30
10
2023
medline:
13
11
2023
pubmed:
11
11
2023
entrez:
11
11
2023
Statut:
epublish
Résumé
An international comparison of health system performance is a popular tool of health policy analysis. However, the efficiency evaluation of health systems is a practical example of an international comparison in which non-homogeneity is expected. The objective of this paper is to evaluate the efficiency of health systems by models in which a degree of non-homogeneity among countries is considered. We study the problem of non-homogeneity of health systems in the theoretical framework of the data envelopment analysis (DEA), which is a popular method of efficiency evaluation with hundreds of applications from various fields. DEA assume the homogeneity of production units and the homogeneity of the environment in which the production units operate. Hence, we compiled a summary of 14 recommendations on how to deal with the non-homogeneity in the DEA models. The analysed sample includes 38 OECD member countries. The data are from the year 2019. As an example, we evaluated the health system efficiency of the Czech Republic. We used the DEA models with the neighbourhood measure of distance and the constraint limiting the comparison of countries with different levels of economic development. The health system inputs were the numbers of physicians, nurses, and hospital beds. In the production of the intermediate outputs (doctor consultations, inpatient care discharges), the Czech Republic should look at Poland, Slovakia and Slovenia. In the production of health outcomes (life expectancy), the peer countries are France, Italy and Switzerland. The results of the DEA analysis are only indicative because no single analytical method can determine whether a health system is better or worse than others. We need to combine different methods, and DEA is one of them. We consider DEA as an exploratory method, not a method providing definitive answers.
Sections du résumé
BACKGROUND
BACKGROUND
An international comparison of health system performance is a popular tool of health policy analysis. However, the efficiency evaluation of health systems is a practical example of an international comparison in which non-homogeneity is expected. The objective of this paper is to evaluate the efficiency of health systems by models in which a degree of non-homogeneity among countries is considered.
METHODS
METHODS
We study the problem of non-homogeneity of health systems in the theoretical framework of the data envelopment analysis (DEA), which is a popular method of efficiency evaluation with hundreds of applications from various fields. DEA assume the homogeneity of production units and the homogeneity of the environment in which the production units operate. Hence, we compiled a summary of 14 recommendations on how to deal with the non-homogeneity in the DEA models. The analysed sample includes 38 OECD member countries. The data are from the year 2019.
RESULTS
RESULTS
As an example, we evaluated the health system efficiency of the Czech Republic. We used the DEA models with the neighbourhood measure of distance and the constraint limiting the comparison of countries with different levels of economic development. The health system inputs were the numbers of physicians, nurses, and hospital beds. In the production of the intermediate outputs (doctor consultations, inpatient care discharges), the Czech Republic should look at Poland, Slovakia and Slovenia. In the production of health outcomes (life expectancy), the peer countries are France, Italy and Switzerland.
CONCLUSIONS
CONCLUSIONS
The results of the DEA analysis are only indicative because no single analytical method can determine whether a health system is better or worse than others. We need to combine different methods, and DEA is one of them. We consider DEA as an exploratory method, not a method providing definitive answers.
Identifiants
pubmed: 37950241
doi: 10.1186/s12913-023-10246-8
pii: 10.1186/s12913-023-10246-8
pmc: PMC10638690
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1237Subventions
Organisme : Vysoká Škola Ekonomická v Praze
ID : IP400040
Informations de copyright
© 2023. The Author(s).
Références
Health Policy. 2004 Jul;69(1):55-72
pubmed: 15484607
Lancet Glob Health. 2022 Dec;10(12):e1715-e1743
pubmed: 36209761
Health Care Manag Sci. 2003 Nov;6(4):203-18
pubmed: 14686627
Expert Syst Appl. 2022 Dec 30;210:118362
pubmed: 35958804
J Glob Health. 2018 Jun;8(1):010407
pubmed: 29564084
Appl Health Econ Health Policy. 2023 Mar;21(2):205-224
pubmed: 36575334
Eur J Public Health. 2013 Apr;23(2):195-201
pubmed: 23402806
Pharmacoecon Open. 2017 Sep;1(3):203-221
pubmed: 29441492
Health Econ Rev. 2021 Oct 12;11(1):40
pubmed: 34642864